Ghent University Academic Bibliography

Advanced

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

BERT VANDER CRUYSSEN UGent, Stijn Van Looy UGent, Bart Wyns UGent, R WESTHOVENS, P DUREZ, M MALAISE, L VERBRUGGEN, N VASTESAEGER, A GELDHOF and Luc Boullart UGent, et al. (2005) ARTHRITIS RESEARCH & THERAPY. 7(5).
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
ARTHRITIS RESEARCH & THERAPY
Arthritis Res. Ther.
volume
7
issue
5
pages
R1063-R1071 pages
publisher
BIOMED CENTRAL LTD
Web of Science type
Article
Web of Science id
000231020200017
JCR category
RHEUMATOLOGY
JCR impact factor
2.965 (2005)
JCR rank
8/22 (2005)
JCR quartile
2 (2005)
ISSN
1478-6362
DOI
1854/3803
language
English
UGent publication?
yes
classification
A1
id
350420
handle
http://hdl.handle.net/1854/LU-350420
date created
2005-12-23 15:31:00
date last changed
2008-06-13 10:59:47
@article{350420,
  author       = {VANDER CRUYSSEN, BERT and Van Looy, Stijn and Wyns, Bart and WESTHOVENS, R and DUREZ, P and MALAISE, M and VERBRUGGEN, L and VASTESAEGER, N and GELDHOF, A and Boullart, Luc and De Keyser, Filip},
  issn         = {1478-6362},
  journal      = {ARTHRITIS RESEARCH \& THERAPY},
  language     = {eng},
  number       = {5},
  pages        = {R1063-R1071},
  publisher    = {BIOMED CENTRAL LTD},
  title        = {DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment},
  url          = {http://dx.doi.org/1854/3803},
  volume       = {7},
  year         = {2005},
}

Chicago
VANDER CRUYSSEN, BERT, Stijn Van Looy, Bart Wyns, R WESTHOVENS, P DUREZ, M MALAISE, L VERBRUGGEN, et al. 2005. “DAS28 Best Reflects the Physician’s Clinical Judgment of Response to Infliximab Therapy in Rheumatoid Arthritis Patients: Validation of the DAS28 Score in Patients Under Infliximab Treatment.” Arthritis Research & Therapy 7 (5): 1063.
APA
VANDER CRUYSSEN, B., Van Looy, S., Wyns, B., WESTHOVENS, R., DUREZ, P., MALAISE, M., VERBRUGGEN, L., et al. (2005). DAS28 best reflects the physician’s clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. ARTHRITIS RESEARCH & THERAPY, 7(5), 1063.
Vancouver
1.
VANDER CRUYSSEN B, Van Looy S, Wyns B, WESTHOVENS R, DUREZ P, MALAISE M, et al. DAS28 best reflects the physician’s clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. ARTHRITIS RESEARCH & THERAPY. BIOMED CENTRAL LTD; 2005;7(5):1063.
MLA
VANDER CRUYSSEN, BERT, Stijn Van Looy, Bart Wyns, et al. “DAS28 Best Reflects the Physician’s Clinical Judgment of Response to Infliximab Therapy in Rheumatoid Arthritis Patients: Validation of the DAS28 Score in Patients Under Infliximab Treatment.” ARTHRITIS RESEARCH & THERAPY 7.5 (2005): 1063. Print.